ASX:AVH AVITA Medical (AVH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About AVITA Medical Stock (ASX:AVH) 30 days 90 days 365 days Advanced Chart Get AVITA Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume27.28 million shsAverage VolumeN/AMarket CapitalizationA$226.55 millionP/E RatioN/ADividend Yield0.30%Price TargetN/AConsensus RatingN/A Company Overview AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California. Read More Receive AVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AVH Stock News HeadlinesAvita’s new drug program gives unused meds to patients in needJuly 7, 2025 | msn.comAsk the analyst: Can ASX growth story turn a profit before it’s too late?July 2, 2025 | morningstar.com.auMMiss This Window And You Miss EverythingThere’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the phase when momentum builds, news turns bullish, and markets ignite. Inside The Crypto Code Workshop, you’ll get the roadmap to ride this wave — and $10 in free Bitcoin just for showing up.July 18 at 2:00 AM | Crypto Swap Profits (Ad)AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELLJune 9, 2025 | finance.yahoo.comAVITA Medical’s Cohealyx shows promise in wound careJune 7, 2025 | investing.comAVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough AwardsJune 4, 2025 | finance.yahoo.comAvita shares plunge despite Q1 revenue liftMay 9, 2025 | msn.comAVITA Medical, Inc. (NASDAQ:RCEL) Q1 2025 Earnings Call TranscriptMay 9, 2025 | insidermonkey.comSee More Headlines AVH Stock Analysis - Frequently Asked Questions How were AVITA Medical's earnings last quarter? AVITA Medical, Inc. (ASX:AVH) issued its quarterly earnings results on Thursday, February, 28th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.01. AVITA Medical had a negative trailing twelve-month return on equity of 39.79% and a negative net margin of 77.47%. What other stocks do shareholders of AVITA Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that AVITA Medical investors own include AVITA MED LTD/S (AVMXY), Avita Medical (RCEL), Boundless Bio (BOLD), Northern Dynasty Minerals (NAK), Orchid Island Capital (ORC), 88 Energy (88E) and Magellan Financial Group (MFG). Company Calendar Last Earnings2/28/2019Today7/18/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryElectronic Equipment Current SymbolASX:AVH CIKN/A Webwww.avitamedical.com Phone661-367-9170FaxN/AEmployees207Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$49.83 million Net Margins-77.47% Pretax MarginN/A Return on Equity-39.79% Return on Assets-38.98% Debt Debt-to-Equity Ratio0.36 Current Ratio8.18 Quick Ratio9.32 Sales & Book Value Annual SalesA$54.14 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.47 Book ValueA$1.00 per share Price / BookN/AMiscellaneous Outstanding Shares129,950,000Free FloatN/AMarket CapA$226.55 million OptionableNot Optionable Beta1.54 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (ASX:AVH) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.